Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic algorithm for #MPN Free access: https://t.co/iKPOqoO32L #hemepath #mpnsm https://t.co/hHGLJUXUTz
Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jan 2024 – May 2025Where it's discussed
-
X / Twitter178 posts
-
YouTube2 videos
AI synopsis
What people are saying
Several discussions highlight key aspects of essential thrombocythemia, such as the mutation details (JAK2/CALR/MPL) and diagnostic criteria, with users referencing phrases like 'excellent review' and 'practical diagnostic algorithm.' The enthusiastic tone and terms like 'hot off the press' contribute to a sense of urgency and excitement around the publication, highlighting its significance in the medical community.
The majority of discussions show strong support for the findings and importance of the publication.
Posts indicate a high level of curiosity and relevance concerning essential thrombocythemia updates.
While some posts reflect a basic understanding, others, like those mentioning specific diagnostic algorithms, indicate moderate engagement.
Users generally perceive the publication as influential, though the focus seems more on disseminating information than discussing broader implications.
Abstract in brief
- Essential thrombocythemia (ET) is a blood disorder caused by mutations in the JAK2 gene, leading to high platelet counts and potential complications like blood clots and transformation into other serious diseases.
- Diagnosis of ET requires confirming high platelet levels while ruling out other similar blood disorders, and bone marrow tests typically show increased megakaryocytes.
- The prognosis for ET patients varies, with median survival around 18 years, but younger patients may live over 35 years, and risk factors for thrombosis depend on age and mutation status.
Top posts
Most liked on X and BlueskyAll you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi. Crystal clear writing that only a true expert can do. #MedTwitter https://t.co/KGCsiWrRic
Essential Thrombocythemia in a tweet •JAK2/CALR/MPL mutated •Females >Males •Spectrum: Asymptomatic ➡️ Thrombosis •Labs: no anemia, LDH normal •BM: Large megakaryocytes in loose clusters
ET vs Prefibrotic MF https://t.co/LGfKS3Lo2F https://t.co/7beqNqU0Rn
A thorough 2024 update on #essentialthrombocythemia authored by Dr. Ayalew Tefferi https://t.co/ZMPuLcLBhs
#TrombocitemiaEsencial
All mentions
Impact of Low Iron on Polycythemia Vera Diagnosis
Polycythemia vera (PV) is a blood disorder caused by JAK2 mutations, leading to increased red blood cell production. Diagnosing PV often involves detecting the JAK2 mutation and checking hemoglobin levels. This video…
Polycythemia Vera: Diagnosis and Treatment Overview
Explore the complexities of polycythemia vera, a blood disorder caused by JAK2 mutations. This video delves into diagnosis, including JAK2 mutation detection and effective treatment strategies aimed at reducing blood…
[https://t.co/u7YB72DTyb]
RT @nihardesai89: Essential Thrombocythemia in a tweet •JAK2/CALR/MPL mutated •Females >Males •Spectrum: Asymptomatic ➡️ Thrombosis •Labs…
RT @nihardesai89: Essential Thrombocythemia in a tweet •JAK2/CALR/MPL mutated •Females >Males •Spectrum: Asymptomatic ➡️ Thrombosis •Labs…
RT @nihardesai89: Essential Thrombocythemia in a tweet •JAK2/CALR/MPL mutated •Females >Males •Spectrum: Asymptomatic ➡️ Thrombosis •Labs…
RT @nihardesai89: Essential Thrombocythemia in a tweet •JAK2/CALR/MPL mutated •Females >Males •Spectrum: Asymptomatic ➡️ Thrombosis •Labs…
RT @nihardesai89: Essential Thrombocythemia in a tweet •JAK2/CALR/MPL mutated •Females >Males •Spectrum: Asymptomatic ➡️ Thrombosis •Labs…
RT @nihardesai89: Essential Thrombocythemia in a tweet •JAK2/CALR/MPL mutated •Females >Males •Spectrum: Asymptomatic ➡️ Thrombosis •Labs…
RT @nihardesai89: Essential Thrombocythemia in a tweet •JAK2/CALR/MPL mutated •Females >Males •Spectrum: Asymptomatic ➡️ Thrombosis •Labs…
RT @nihardesai89: Essential Thrombocythemia in a tweet •JAK2/CALR/MPL mutated •Females >Males •Spectrum: Asymptomatic ➡️ Thrombosis •Labs…
Essential Thrombocythemia in a tweet •JAK2/CALR/MPL mutated •Females >Males •Spectrum: Asymptomatic ➡️ Thrombosis •Labs: no anemia, LDH normal •BM: Large megakaryocytes in loose clusters
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @FAPsGal: #TrombocitemiaEsencial
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @FAPsGal: #TrombocitemiaEsencial
#TrombocitemiaEsencial
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
RT @AjHematology: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic…
Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management Including a practical diagnostic algorithm for #MPN Free access: https://t.co/iKPOqoO32L #hemepath #mpnsm https://t.co/hHGLJUXUTz
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @AjHematology: A comprehensive and up to date review in essential thrombocythemia - Tefferi/Vannucchi/Barbui @n_gangat https://t.co/TG…
RT @MostafaFaisal14: ET vs Prefibrotic MF https://t.co/LGfKS3Lo2F https://t.co/7beqNqU0Rn
RT @MostafaFaisal14: ET vs Prefibrotic MF https://t.co/LGfKS3Lo2F https://t.co/7beqNqU0Rn
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @MostafaFaisal14: ET vs Prefibrotic MF https://t.co/LGfKS3Lo2F https://t.co/7beqNqU0Rn
A comprehensive and up to date review in essential thrombocythemia - Tefferi/Vannucchi/Barbui @n_gangat https://t.co/TGn0PY3Vi6
American Journal of Hematology | Blood Research Journal | Wiley Online Library https://t.co/GjeI2exgv5
RT @MostafaFaisal14: ET vs Prefibrotic MF https://t.co/LGfKS3Lo2F https://t.co/7beqNqU0Rn
RT @MostafaFaisal14: ET vs Prefibrotic MF https://t.co/LGfKS3Lo2F https://t.co/7beqNqU0Rn
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @MostafaFaisal14: ET vs Prefibrotic MF https://t.co/LGfKS3Lo2F https://t.co/7beqNqU0Rn
A thorough 2024 update on #essentialthrombocythemia authored by Dr. Ayalew Tefferi https://t.co/ZMPuLcLBhs
RT @MostafaFaisal14: ET vs Prefibrotic MF https://t.co/LGfKS3Lo2F https://t.co/7beqNqU0Rn
Diagnostic approach to MPNs https://t.co/LGfKS3Lo2F https://t.co/ES3h3mhrBw
ET vs Prefibrotic MF https://t.co/LGfKS3Lo2F https://t.co/7beqNqU0Rn
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management https://t.co/rJajRCJcWK
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
RT @VincentRK: All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi.…
All you need to know about Essential Thrombocythemia — an excellent review by the master in the field, Dr. Ayalew Tefferi. Crystal clear writing that only a true expert can do. #MedTwitter https://t.co/KGCsiWrRic
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @sanamloghavi: 2024 updates on ET .. just out in @AjHematology #MPNsm https://t.co/SV4anrm4xH
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
RT @smbenlazar: Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management |American Journal of Hematology |…
New ET updates, hot off the press for 2024. #ET #hemetwitter #MedTwitter https://t.co/t7W1q00JdC